# EFFECT OF SELECTIVE COX-2 INHIBITOR (ETORICOXIB) ALONG WITH SCALING AND ROOT PLANING (SRP) ON CLINICAL PARAMETERS AND SALIVARY LEVEL OF SUPEROXIDE DISMUTASE IN CHRONIC GENERALIZED PERIODONTITIS A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOUBLE-MASKED RANDOMIZED CONTROLLED TRIAL (RCT).

> **NCT02149758** · PHASE4 · COMPLETED · sponsor: **Tatyasaheb Kore Dental College** · enrollment: 40 (actual)

## Conditions studied

- Cyclooxygenase Two Inhibitors
- Etoricoxib
- Periodontitis
- Superoxide Dismutase
- Saliva

## Interventions

- **DRUG:** Etoricoxib

## Key facts

- **NCT ID:** NCT02149758
- **Lead sponsor:** Tatyasaheb Kore Dental College
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2014-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02149758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02149758, "EFFECT OF SELECTIVE COX-2 INHIBITOR (ETORICOXIB) ALONG WITH SCALING AND ROOT PLANING (SRP) ON CLINICAL PARAMETERS AND SALIVARY LEVEL OF SUPEROXIDE DISMUTASE IN CHRONIC GENERALIZED PERIODONTITIS A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOUBLE-MASKED RANDOMIZED CONTROLLED TRIAL (RCT).". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02149758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*